Peptide record

TPDB87395

RADA16-I Selfassembly modified_plain modified
16 source-reported length (unverified)
Basic Information
TPDB87395
RADA16-I
Selfassembly
Self-assembling and biomaterial peptides
PMC
modified_plain
Yes
A modified selfassembly peptide record curated from PMC, without an available 3D structural model. Source-reported length: 16 (unverified).
C-terminal: Amidation
Sequence
Ac-RADARADARADARADA-CONH2

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
16 source-reported length (unverified)
Self-Assembly Information 2 records
Record 1 PMC

Source

34178214
10.3389/fbioe.2021.679525
Clinical Use of the Self-Assembling Peptide RADA16: A Review of Current and Future Trends in Biomedicine

Self-Assembly

Nanostructure formation
Interwoven beta-sheet nanofiber hydrogel
Physiological pH and ionic biological fluids
Selfassembly; Nanostructure=Interwoven beta-sheet nanofiber hydrogel; Trigger=Physiological pH and ionic biological fluids
TEM/SEM beta-sheet CD rheology clinical/preclinical evidence
Hemostasis wound healing tissue regeneration
active peptide hydrogel scaffold
PMC
Selfassembly
Record 2 PMC

Source

23173072
10.1155/2012/853615
Molecular Mechanisms of RADA16-1 Peptide on Fast Stop Bleeding in Rat Models

Self-Assembly

Nanostructure formation
Nanofiber hydrogel scaffold
Contact with wound/blood physiological environment
Selfassembly; Nanostructure=Nanofiber hydrogel scaffold; Trigger=Contact with wound/blood physiological environment
Self-assembly described nanofiber scaffold animal bleeding models
Hemostasis
active peptide hydrogel scaffold
PMC
Selfassembly
Evidence Records 2 records
Evidence 1 Selfassembly

Activity

Nanostructure formation
Selfassembly Nanostructure=Interwoven beta-sheet nanofiber hydrogel Trigger=Physiological pH and ionic biological fluids
Interwoven beta-sheet nanofiber hydrogel

Source & Reference

NA
PMC
10.3389/fbioe.2021.679525

Other

N-terminal acetylation C-terminal amidation
Hemostasis wound healing tissue regeneration
active peptide hydrogel scaffold
Physiological pH and ionic biological fluids
TEM/SEM beta-sheet CD rheology clinical/preclinical evidence
34178214
Clinical Use of the Self-Assembling Peptide RADA16: A Review of Current and Future Trends in Biomedicine
Commercial formulation PuraStat also reported as RADA16-1.
Evidence 2 Selfassembly

Activity

Nanostructure formation
Selfassembly Nanostructure=Nanofiber hydrogel scaffold Trigger=Contact with wound/blood physiological environment
Nanofiber hydrogel scaffold

Source & Reference

NA
PMC
10.1155/2012/853615

Other

N-terminal acetylation C-terminal amidation
Hemostasis
active peptide hydrogel scaffold
Contact with wound/blood physiological environment
Self-assembly described nanofiber scaffold animal bleeding models
23173072
Molecular Mechanisms of RADA16-1 Peptide on Fast Stop Bleeding in Rat Models
Duplicate sequence retained because therapeutic evidence is hemostasis-focused.
Additional Detail Fields 7 fields
Physiological pH and ionic biological fluids Contact with wound/blood physiological environment
N-terminal acetylation C-terminal amidation
Commercial formulation PuraStat also reported as RADA16-1. Duplicate sequence retained because therapeutic evidence is hemostasis-focused.
34178214 23173072
Clinical Use of the Self-Assembling Peptide RADA16: A Review of Current and Future Trends in Biomedicine Molecular Mechanisms of RADA16-1 Peptide on Fast Stop Bleeding in Rat Models
Hemostasis wound healing tissue regeneration
active peptide hydrogel scaffold